BACK TO TEAM PAGE

Designation

Venture Partner


Last major assignment

Founding Partner of Chicago Growth Partners

Arda Minocherhomjee

Dr. Minocherhomjee is a founding Partner of Chicago Growth Partners. Prior to founding CGP, he was a Managing Director at William Blair Capital Partners and, currently, is a Managing Director and member of the Board of Managers of WBCP VI and VII and a Principal Senior Healthcare Analyst at William Blair & Company. As head of the firm’s Healthcare Research Group, Dr. Minocherhomjee covered several sectors, including drugs/drug delivery, medical devices and selected healthcare services. He was a Wall Street Journal "All-Star Analyst" in both medical device and pharmaceutical sectors. Select current and past directorships include: Atherogenics, CryoCor, DJ Pharma, EndoGastric Solutions, Favrille, Genoptix, Morton Grove Pharmaceuticals, NuVasive, PharmaResearch Corporation, POINT Biomedical, Proteome and TargeGen. Dr. Minocherhomjee received a MS (Pharmacology) from the University of Toronto, a PhD and a MBA from the University of British Columbia, and was a post-doctoral fellow in Pharmacology at the University of Washington Medical School.


Industry Expertise

Healthcare


Functional Expertise

Private Equity, M&A, corporate development, portfolio management

Designation

Venture Partner


Last major assignment

Founding Partner of Chicago Growth Partners

Arda Minocherhomjee

Dr. Minocherhomjee is a founding Partner of Chicago Growth Partners. Prior to founding CGP, he was a Managing Director at William Blair Capital Partners and, currently, is a Managing Director and member of the Board of Managers of WBCP VI and VII and a Principal Senior Healthcare Analyst at William Blair & Company. As head of the firm’s Healthcare Research Group, Dr. Minocherhomjee covered several sectors, including drugs/drug delivery, medical devices and selected healthcare services. He was a Wall Street Journal "All-Star Analyst" in both medical device and pharmaceutical sectors. Select current and past directorships include: Atherogenics, CryoCor, DJ Pharma, EndoGastric Solutions, Favrille, Genoptix, Morton Grove Pharmaceuticals, NuVasive, PharmaResearch Corporation, POINT Biomedical, Proteome and TargeGen. Dr. Minocherhomjee received a MS (Pharmacology) from the University of Toronto, a PhD and a MBA from the University of British Columbia, and was a post-doctoral fellow in Pharmacology at the University of Washington Medical School.


Industry Expertise

Healthcare


Functional Expertise

Private Equity, M&A, corporate development, portfolio management